Irini Sereti, M.D.

Trials

Studies that name Irini Sereti, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:34 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT04408950 · Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects

  National Institute of Allergy and Infectious Diseases (NIAID) · completed · Immunodeficiency · principal investigator
• N/A
  NCT04401436 · COVID-19 Associated Lymphopenia Pathogenesis Study in Blood

  National Institute of Allergy and Infectious Diseases (NIAID) · completed · Coronavirus Disease 2019 · principal investigator
• Ph1
  NCT04097561 · Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

  National Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Idiopathic CD4 Lymphopenia · principal investigator
• Ph1
  NCT02652546 · CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)

  National Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV, Inflammation · principal investigator
• N/A
  NCT02147405 · PET Imaging and Lymph Node Assessment of IRIS in People With AIDS

  National Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Immune Reconstitution Inflammatory Syndrome · principal investigator
• Ph2
  NCT02081638 · Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study

  National Institute of Allergy and Infectious Diseases (NIAID) · completed · Human Immunodeficiency Virus · principal investigator
• Ph2
  NCT02015013 · Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

  National Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Idiopathic CD4-Positive, T-Lymphocytopenia · principal investigator
• N/A
  NCT01611402 · Gene Expression in HIV and Tuberculosis Co-infection

  National Institute of Allergy and Infectious Diseases (NIAID) · completed · Tuberculosis · principal investigator
• N/A
  NCT00988780 · Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients

  Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · unknown · Immune Reconstitution Inflammatory Syndrome, HIV, HIV Infections · principal investigator
• N/A
  NCT00867269 · Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

  National Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Idiopathic CD4+ Lymphocytopenia, Cryptococcal Meningitis, Warts · principal investigator
• N/A
  NCT00286767 · Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy

  National Institute of Allergy and Infectious Diseases (NIAID) · completed · Immune Reconstitution Inflammatory Syndrome · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.